PRECISE Scoring: Enhancing Clinical Decision-Making
Dr Olly Hulson, Consultant Radiologist at Leeds Teaching Hospitals NHS Trust presents the role of MRI and the PRECISE criteria in active surveillance for prostate cancer.
Key Challenges in Active Surveillance – Insights and Solutions
Professor Vincent Gnanapragasam, Professor of Urology and Honorary Consultant Urologist, Professor Caroline Moore, NIHR Research Professor and Head of Urology at UCL and Andrew Seggie, Health Influencing Senior Officer- Earlier Diagnosis Lead at Prostate Cancer UK, present insights into improving active surveillance for prostate cancer.
The Importance of Opening up Conversations on Sexual Wellbeing
Sophie Smith and Deidre Vlotman, Specialist Nurses at Prostate Cancer UK, present a practical guide on opening up conversations on sexual wellbeing.
A report from a UK clinical consensus on PSA blood testing
Our limited-time only webinar that was recorded at the Guidelines conference in November 2024, about optimising the use of the PSA blood test in asymptomatic men for early prostate cancer detection in primary care. *This recording will expire in November 2025*
Counselling Patients on the PSA Blood Test
Prostate Cancer UK’s toolkit offers an overview of updated PSA test guidance per the 2019 NICE guidelines, aiming to improve diagnostic accuracy and safety, and assists healthcare professionals in discussing the test’s pros and cons with patients to support informed decision-making.
The professional development framework for specialist prostate cancer nursing
This Professional Development Framework, supported by Prostate Cancer UK and developed by nurses, researchers, and patients, outlines the essential skills, knowledge, and training for nurses advancing in prostate cancer care.
Tens of thousands fewer men face harm in prostate cancer diagnosis
Prostate Cancer UK’s new research indicates that improved scans and safer biopsies may allow the UK to launch a prostate cancer screening program, potentially reducing deaths and harms, with the National Screening Committee considering new screening proposals.
Hormones Therapy: living well with ADT
Lisa O’Sullivan, Senior Specialist Nurse at Prostate Cancer UK, presents an overview on Hormone Therapy and Androgen Deprivation Therapy.
Risks, Counselling, and the importance of Active Surveillance
David Thurtle, senior urology registrar in the East of England, introduces you to the importance of Active Surveillance.
Active Surveillance – the Wild West of prostate cancer management
Vincent J Gnanapragasam, Professor of Urology in the University of Cambridge and an Honorary Consultant Urologist at Addenbrooke’s Hospital in Cambridge, presents the difficulties and challenges of Active Surveillance.